HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02655731

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Cardioangiologisches Centrum Bethanien (from the registry)
Registry
  • NCT NCT02655731
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02655731. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-03-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate
Acronym
HEURECA
Intervention (Device)
PVI with HeartLight
Lead sponsor
Cardioangiologisches Centrum Bethanien (class: other)

Record details

Record id
cardio:ct-nct02655731
Content hash
200e033431bd1f30cfa7dd904d6df7e1b4ecdb52256abfd72e322831ceba8774